Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: Year-three results
- 31 January 2000
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (1), 103-111
- https://doi.org/10.1016/s0149-2918(00)87981-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Systemic Adverse Effects of Topical Ophthalmic AgentsDrugs & Aging, 1997
- BrimonidineExpert Opinion on Investigational Drugs, 1997
- Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: A review of safety, efficacy, dose response, and dosing studiesSurvey of Ophthalmology, 1996
- Medical treatment of glaucoma--a reappraisal of the risks.British Journal of Ophthalmology, 1996
- The Cardiovascular, Pulmonary, and Ocular Hypotensive Effects of 0.2% BrimonidineArchives of Ophthalmology (1950), 1995
- Changes in depressive status associated with topical Beta-blockersInternational Ophthalmology, 1992
- Adverse Respiratory and Cardiovascular Events Attributed to Timolol Ophthalmic Solution, 1978–1985American Journal of Ophthalmology, 1986
- Efficacy of combining timolol with other antiglaucoma medicationsSurvey of Ophthalmology, 1983
- Shortterm “escape” and longterm “drift.”. The dissipation effects of the beta adrenergic blocking agentsSurvey of Ophthalmology, 1983
- Adverse Reactions from Timolol AdministrationOphthalmology, 1980